Regency Centers (REG)

Nasdaq Real Estate Retail REITs S&P 500
$74.84
-1.44 (-1.89%)
Close of Nov 06, 2026 · end-of-day data

REG 8-K filings in 2026

Every material Form 8-K Regency Centers filed with the SEC in 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.

Briefs in 2026616 on record in all
Latest filing in 2026Nov 05, 2026earnings
High impact (4-5)2of 6 briefs
TonePositive4Neutral2
earnings 3guidance 1financing 1leadership 1
Nov 5, 5:15 PM ET

Regency Centers Reports Third Quarter 2026 Results and Increases Dividend

Positive earnings 2.027.01

Regency Centers reported third quarter 2026 net income attributable to common shareholders of $75.1 million, or $0.41 per diluted share, alongside Nareit FFO of $1.23 per diluted share. The company raised its full-year 2026 Core Operating Earnings guidance midpoint and increased its quarterly common stock dividend by 6% to $0.800 per share. Shareholders experienced higher year-over-year Same Property NOI growth and strong leasing spreads during the quarter.

  • Reported Q3 2026 Net Income Attributable to Common Shareholders of $75.1 million, or $0.41 per diluted share.
  • Raised full year 2026 Core Operating Earnings guidance range to $4.65 to $4.67 per diluted share.
  • Increased quarterly common stock cash dividend by 6% to $0.800 per share.
  • Same Property NOI increased year-over-year by 5.1% for the third quarter of 2026.
Read the filing on SEC.gov ↗
Jul 29, 4:22 PM ET

Regency Centers Q2 Nareit FFO rises to $1.21 per share; raises 2026 guidance

Positive guidance Written later 2.027.01

Regency Centers reported second quarter 2026 results on July 29, 2026, with net income attributable to common shareholders of $112.4 million, or $0.61 per diluted share, up from $0.56 a year earlier. The company raised its full-year 2026 Nareit FFO and Core Operating Earnings guidance, which gives shareholders a higher outlook for per-share earnings.

  • Q2 2026 Nareit FFO was $226.3 million, or $1.21 per diluted share, versus $1.16 in Q2 2025
  • Full-year 2026 Nareit FFO guidance raised to $4.84 to $4.88 per diluted share, from $4.83 to $4.87
  • Same Property NOI rose 3.8% year over year in the second quarter, and Same Property percent leased reached 96.9% at June 30, 2026
Read the filing on SEC.gov ↗
Apr 29, 4:27 PM ET

Regency Centers Q1 Net Income Rises to $0.68 per Share; Raises 2026 EPS Guidance

Positive earnings Written later 2.027.01

Regency Centers reported first-quarter 2026 net income attributable to common shareholders of $125.1 million, or $0.68 per diluted share, up from $0.58 a year earlier. The company raised its 2026 net income per diluted share guidance to $2.45-$2.49 from $2.35-$2.39 and reaffirmed its Nareit FFO and Core Operating Earnings guidance.

  • Q1 2026 Nareit FFO was $1.20 per diluted share, up from $1.15; Core Operating Earnings was $1.16, up from $1.09.
  • Same Property NOI rose 4.4% year over year, and Same Property percent leased was 96.6%, flat year over year.
  • 2026 net income per diluted share guidance raised to $2.45-$2.49 from $2.35-$2.39; Nareit FFO guidance of $4.83-$4.87 unchanged.
  • Board authorized a share repurchase program of up to $500 million on February 4, 2026, running until February 28, 2029.
Read the filing on SEC.gov ↗
Feb 17, 4:46 PM ET

Regency Centers sets up up to $500 million equity distribution program with RBC

Neutral financing Written later 1.01

Regency Centers entered into an equity distribution agreement with RBC Capital Markets and Royal Bank of Canada allowing it to sell common stock and forward sale agreements with an aggregate sales price of up to $500 million. The filing says the company will not initially receive proceeds from borrowed shares sold by a forward seller, and proceeds depend on how and when forward sale agreements settle, so the dilution and cash impact to shareholders will depend on future sales.

  • Shares may be sold from time to time with an aggregate offering price of up to $500 million, including through forward sale agreements
  • Sales agent commissions will not exceed 2.0% of gross sales prices
  • Shares will be issued under an automatic shelf registration on Form S-3 filed February 17, 2026
Read the filing on SEC.gov ↗
Feb 6, 4:44 PM ET

Regency Centers director C. Ronald Blankenship to retire from board after 2026 annual meeting

Neutral leadership Written later 5.02

Regency Centers said director C. Ronald Blankenship notified the company on February 4, 2026, that he will not stand for re-election and will retire from the Board when his current term expires, immediately after the 2026 Annual Meeting of Shareholders. The company said the retirement was not due to any disagreement over its operations, policies or practices, and it thanked him for 25 years of service.

  • Notice of intention to retire given on February 4, 2026
  • Retirement takes effect upon expiration of current term, immediately after the 2026 Annual Meeting of Shareholders
  • Mr. Blankenship served 25 years, described by the Board as a leader of the Board
  • Company states retirement was not due to any disagreement with the company
Read the filing on SEC.gov ↗
Feb 5, 4:28 PM ET

Regency Centers Q4 core earnings rise to $1.12 per share; 2026 guidance issued

Positive earnings Written later 2.027.01

Regency Centers reported fourth-quarter and full-year 2025 results on February 5, 2026, with core operating earnings and Nareit FFO per diluted share higher than a year earlier. The company also issued initial 2026 guidance, which projects core operating earnings of $4.59 to $4.63 per share, above the $4.41 reported for 2025. Reported net income per share is expected to fall to $2.35 to $2.39 in 2026, from $2.82 in 2025, which included a $72.2 million gain from a partial distribution-in-kind transaction.

  • Q4 2025 Nareit FFO was $1.17 per diluted share, up from $1.09 a year earlier
  • Full-year 2025 core operating earnings were $4.41 per diluted share, up 6.8% from $4.13 in 2024
  • 2026 guidance: Nareit FFO of $4.83 to $4.87 and core operating earnings of $4.59 to $4.63 per diluted share
  • 2026 net income per diluted share guidance of $2.35 to $2.39, versus $2.82 in 2025 that included a $72.2 million gain
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Regency Centers filing is on SEC EDGAR ↗. 8-K briefs of other companies →